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It's well known that during the process of tumor promotion, 
tumor specific and non-specific immune responce is suppressed 
which is determined to a great extent by the ability of cancer cells to 
produce a number of biologically active substances, changing the 
immune reactivity. In this sense we can discuss some immunomodu-
lating influence of the tumor which results in changing the indexes 
of immune status of the organism since cancer develops. Some of 
the authors (1,3) presume that the information, obtained by follow­
ing up the indicators of the tumor defending system has no diagnos­
tic value, but in can be in help while controling the effect of treatment 
and prognosing the survival of lung cancer patients. We followed for 
1-year period 19 male patients, all of them smokers, in the average 
age of 56,3 ± 2,4 with squamous cell carcinoma, stage Ilia. The di­
agnosis was confirmed by bronchoscopy with brush biopsy in all 
cases, 14 of the patients had peripheral and the rest 5 - central 
cancer. Nine of the patients had passed radical surgical treatment 
and the rest 10 underwent explorative thoracotomy. As a second 
level of treatment 6 cycles of chemotherapy with Methotrexate t.d. 
300 mg, Cyclophosphamide t. d. 7,2 g, Farmorubicin t.d. 600 mg, Da-
carbazin t.d. 8,4 g was chosen. In these patients we followed a num­
ber of immunologic indexes before and after surgery, during and 
after finishing the chemotherapy. These indicators, typical of the dif­
ferent lines of the immune responce are: phagocytic activity of PMNL, 
total complement (TC), serum immunoglobulins (SI), circulating im­
mune complexes (CIC), E-rosette forming cells (RFC), early and late 
ones. In order to estimate the cell-mediated immune deficiency, be­
fore the operation and before the start of chemotherapy, an intrader­
mal testing with PPD, D5, D7, ТА was performed. The patients were 
closely followed during the whole period of chemotherapy, whidh 
proceeded average 6 months. 
We found a suppression of the cell mediated immunity (CM]) in 
all the patients before starting the cytostatic treatment, while the 
changes of the humoral immune response were many faced. Signifi-
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cantly high levels of CIC were found while the levels of SI were nor-, 
mal. On the other hand the cell-related components of the non-spe­
cific resistancy was activated while the TC remained unchanged. The 
changes in the initial levels of the treated immunologic indexes, re­
spectively the suppression of the CMI that were established might 
find their explaination in the existing deficiency of T-lymphocytes 
and/or with possible presence of some serum or cell-originating fac­
tors, impairing the ability of latest to form Е-rosettes (2,3). Accord­
ing to the results of the intradermal testing, we divided the patients 
into two major groups: I group of 17 patients (64,48%) with data 
showed pre- and post operative cell-mediated immune deficiency, 
established on the negative results from the skin testing against all 
alergenes; II group of 6 patients (35,57%) with pre- and postopera­
tive negative skin reactivity against ТА and preserved reactivity 
against PPD, D5, D7. The data obtained by the close following of the 
immunologic indexes of patients in the I group during and after fin­
ishing the chemotherapy helped us to determine a further suppress­
ion of the CMI, judged by the E-rosettes forming test and high levels 
of CI. Their preservation postoperatively and during the chemother­
apy was valued as a poor prognostic index. The strongly expressed 
suppression of the CMI was corellating with a poor therapeutic effect 
- 2 of the patients died in 9 of them distant hematologic metastases 
were found by ultrasound, x-ray and scintigraphic work up. In the pa­
tients from the II group who had preserved postoperatively their skin 
reactivity against PPD, D5, D7 no further suppression of the CMI after 
the operation and after the chemotherapy was found according to 
the E-RFT. The levels of CIC in serum were significantly low. The clini­
cal follow up during chemotherapy revealed that they kept their func­
tional activity and no data, suggesting distant metastases were 
obtained. 
We presume that the evaluation of the pre- and postoperative 
skin reactivity against the noted allergens in lung cancer patients has 
some diagnostic value, concerning the resectability, the efficiency of 
the complex treatment and the total survival of the patients. The 
strongly expressed suppression of the CMI corellating to a certain 
extent with the suppression of the humoral immunity may be helpful 
as un additional criterion in the complex evaluations of the results of 
chemotherapy of lung cancer patients. 
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